AU4907797A - Methods and compositions for inducing a protective immune response to cancers - Google Patents

Methods and compositions for inducing a protective immune response to cancers

Info

Publication number
AU4907797A
AU4907797A AU49077/97A AU4907797A AU4907797A AU 4907797 A AU4907797 A AU 4907797A AU 49077/97 A AU49077/97 A AU 49077/97A AU 4907797 A AU4907797 A AU 4907797A AU 4907797 A AU4907797 A AU 4907797A
Authority
AU
Australia
Prior art keywords
cancers
inducing
compositions
methods
immune response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49077/97A
Inventor
Hildegund C. J. Ertl
Magdalena Thurin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wistar Institute of Anatomy and Biology
Original Assignee
Wistar Institute of Anatomy and Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wistar Institute of Anatomy and Biology filed Critical Wistar Institute of Anatomy and Biology
Publication of AU4907797A publication Critical patent/AU4907797A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/713Double-stranded nucleic acids or oligonucleotides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU49077/97A 1996-10-10 1997-10-10 Methods and compositions for inducing a protective immune response to cancers Abandoned AU4907797A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2819396P 1996-10-10 1996-10-10
US60028193 1996-10-10
PCT/US1997/018807 WO1998015285A1 (en) 1996-10-10 1997-10-10 Methods and compositions for inducing a protective immune response to cancers

Publications (1)

Publication Number Publication Date
AU4907797A true AU4907797A (en) 1998-05-05

Family

ID=21842078

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49077/97A Abandoned AU4907797A (en) 1996-10-10 1997-10-10 Methods and compositions for inducing a protective immune response to cancers

Country Status (2)

Country Link
AU (1) AU4907797A (en)
WO (1) WO1998015285A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2326685C (en) * 1998-04-22 2013-08-06 Chiron Corporation Enhancing immune responses to genetic immunization by using a chemokine
NO315238B1 (en) 1998-05-08 2003-08-04 Gemvax As Peptides derived from reading frame shift mutations in the TBF <beta> II or BAX gene, and pharmaceutical compositions containing them, nucleic acid sequences encoding such peptides, plasmids, and virus vector-encompassing such nucleic acid
WO2000022124A2 (en) * 1998-10-15 2000-04-20 Canji, Inc. Methods and compositions to induce antitumor response
US6649158B1 (en) 1998-10-15 2003-11-18 Canji, Inc. Methods and compositions to induce antitumor response
US7361329B2 (en) 2000-04-21 2008-04-22 Chemocentryx, Inc. Compositions for inducing an immune response

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994002167A1 (en) * 1992-07-22 1994-02-03 The Trustees Of Princeton University p53 VACCINE

Also Published As

Publication number Publication date
WO1998015285A1 (en) 1998-04-16

Similar Documents

Publication Publication Date Title
AU4303997A (en) Protective structure
AU4898296A (en) Infrared tracer compositions
AU2296695A (en) Individual protective pads for crib balusters
AU4748997A (en) Protective hand covering
HK1068366A1 (en) Thermal protective compositions
AU3874697A (en) Protective shield of emc-type
AU7891898A (en) Protective device
AU3002895A (en) Compositions for enhancing immune function
EP0821698A4 (en) Protective helicobacter antigens
AU1614297A (en) Protective means
IL128806A0 (en) Compositions for immune therapy
AU2086895A (en) Protective canopy
AU6009594A (en) Thermoinsulative protective garments
AU4907797A (en) Methods and compositions for inducing a protective immune response to cancers
IL120489A0 (en) Protective helmet
GB9618071D0 (en) Improvements relating to protective bags
GB9618234D0 (en) Improvements relating to protective bags
ZA961818B (en) Protective means
GB2314144B (en) Protective surface
AU3556697A (en) Protective sleeve
AU5472698A (en) Protective garment
GB9724404D0 (en) Protective garment
GB9625044D0 (en) Protective sleeve
GB9618196D0 (en) Improvements relating to protective pads
AU5262196A (en) Protective helicobacter antigens